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Chronic pancreatitis (CP) is a major cause of morbidity,
accounting for 7400 hospital admissions in the United
Kingdom during the period 2011/2012. The mainstay of
treatment is to avoid precipitating causes, such as alcohol.
Pain is the most debilitating symptom and the symptom
most resistant to treatment, with patients often becoming
reliant on long-term analgesia leading to drug dependency.
The etiology of pain in CP is not completely understood,
though it has been studied extensively. Currently its originhe best option for the management of pain in patients with chronic
Surgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.09.005
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pancreatic duct (PD) which leads to intraductal and inter-
stitial hypertension. An inflammatory response occurs in
the pancreatic tissue mediated by the neuron-specific
proteinase-activated receptor 2 (PAR-2), substance P,
neurokinin A, and calcitonin-gene related peptide (CGRP),
or a combination.1 The resulting fibrosis further contributes
to pain as the pancreas parenchyma loses its ability to
distend during its excretory function.2 This is exacerbated
by the presence of strictures and stones which affect the
ability of the gland to drain. Other factors affecting pain
have also been advocated. Centrally mediated pancreas-
independent pain is a possible contributor and this is due
to chronic visceral input leading to plastic changes in the
brain, which in turn cause a self-perpetuating and sustained
pain.3,4
Treatment has traditionally been medical with analge-
sics and enzyme supplementation, while surgical manage-
ment has been reserved for patients with intractable pain
or complications.5 The aim of surgical procedures is to
decompress the and/or resect the nidus of inflammation.
Surgical denervation strategies are ineffective and not
appropriate as a first-line treatment.1,6,7 Recently, combi-
nation procedures of drainage and local resection have
been increasingly used as an alternative to major resection,
with good success in symptom alleviation and low morbidity
and mortality.8
Endoscopy has had an increasing role in the treatment of
CP. The development of new techniques (PD stenting, stone
removal and sphincterotomy) in combination with better
patient selection has led to an increasing number of pa-
tients being managed without surgery.9e11 However, there
are only a few, small studies available that evaluate the
outcomes of these interventions. While current studies
suggest that surgery is better than endoscopy in the short
term, it is not clear whether these benefits are sustained.
Endoscopic treatments are becoming more complex, for
example, the use of lithotripsy which has not been evalu-
ated in earlier studies. The aim of this study is to provide an
update on evidence evaluating the outcomes of surgery
versus endoscopy for pain control in CP.2. Methods2.1. Study selection
A systematic literature search of the published studies
comparing the outcomes of endoscopic or surgical treat-
ment for CP was performed using a PubMed search covering
the MEDLINE, EMBASE, Ovid, and Cochrane databases.
Publications from January 1994 to October 2014 were
reviewed. The following medical subject headings were
used for the search: chronic pancreatitis, surgery, endo-
scopic, stent, resection, and drainage. These terms, and
their combinations, were also searched as text words. The
“related articles” function was used to broaden the search,
and all abstracts, studies, and citations retrieved were
reviewed. Relevant references of the articles acquired
were also included.Please cite this article in press as: Jawad ZAR, et al., Surgery remains t
pancreatitis: A systematic review and meta-analysis, Asian Journal of2.2. Inclusion and exclusion criteria
Studies were independently assessed by two authors; con-
flicts were resolved by a third assessor until consensus was
reached. Included studies were: (1) human; (2) reported
the indication for surgery; and (3) were written in English.
Excluded studies had failed to: (1) describe their
methods for treatment options; (2) clearly report the out-
comes and variables of interest; (3) data extraction was
impossible or not quantifiable; or (4) there was overlap
between authors and centres. Figure 1 shows the flow chart
of publication selection.
2.3. Variables and outcomes of interest
These include indication for surgery for CP, surgical
methods, result of treatment measured by pain control,
postoperative morbidity and mortality, and recurrent
symptoms. The main focus during the selection process
was the presence of data on pain relief and adequate
follow up.
2.4. Statistical analysis
The meta-analysis was performed in line with recom-
mendations from the Cochrane Collaboration.12 Statistical
analysis of dichotomous variables was performed using the
odds ratio (OR) as the summary statistic. Postprocedural
morbidity and mortality after surgery and endoscopy were
analyzed, and the results were compared. Both were re-
ported with 95% confidence intervals (CIs). An OR of <1
favored the particular type of procedure. The point esti-
mate of the OR was considered statistically significant at
p < 0.05 if the 95% CI did not include 1. In the tabulation
of the results (Figure 2), squares indicate the point esti-
mates of the treatment effect (OR or weighted mean
difference), with 95% CIs indicated by horizontal bars. The
diamond represents the summary estimate from the
pooled studies with 95% CIs. The ManteleHaenszel method
was used to combine the OR for the outcomes of interest
using a “random-effect” meta-analytical technique. This
is a more conservative method than a fixed effects model
and takes into account clinical heterogeneity. Statistical
heterogeneity, by inspection of the I2 statistic, reveals no
observed heterogeneity across the studies when the value
is close to 0%. Heterogeneity was also assessed by
graphical exploration with funnel plots to evaluate pub-
lication bias. Statistical analysis was performed using
Review Manager for Windows, version 5.3 (The Nordic
Cochrane Centre, The Cochrane Collaboration, England,
UK) and SPSS for Windows, version 15.0 (SPSS Inc., Chi-
cago, IL, USA). Categorical variables were analyzed using
the Fischer’s exact test.
3. Results
3.1. Description of studies
The systematic literature search initially identified 1733
potential articles. After irrelevant citations were excludedhe best option for the management of pain in patients with chronic
Surgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.09.005
Records iden?fied through 
database searching 
(n = 1733)
Records a?er ineligible studies removed 
(n = 137)
Records screened 
(n = 116)
Records excluded (non-
English and small studies)
(n = 21)
Full-text ar?cles excluded 
(n = 95)
Studies included in 
qualita?ve synthesis 
(n = 19)
Studies included in 
quan?ta?ve synthesis 
(meta-analysis)
(n = 2)
Records excluded 
(n = 1596)
Eligible studies 
(n = 21)
Figure 1 Study selection flow-chart.
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reviewed for further assessment (Figure 1). The titles and
abstracts were first reviewed eliminating non-English ones
(7 articles), as well as case reports and small volume trials
or series, as defined by patient numbers of <15 (14 arti-
cles). A further 95 articles were excluded because of
insufficient data on pain relief, including those with follow
up of <6 months.
Only three of the 21 studies eventually selected were
randomized control trials (RCTs).13e15 One of these was a
report of longer-term data from the same group.15 ThePlease cite this article in press as: Jawad ZAR, et al., Surgery remains t
pancreatitis: A systematic review and meta-analysis, Asian Journal oflatest paper from this group was included in the meta-
analysis to avoid duplication of results.
A total of 2754 patients were included in the 21 studies
finally selected (Table 1). Of these, 1602 underwent sur-
gery, including resection, drainage, and combination pro-
cedures (i.e., Whipple’s resection, distal resection, Frey’s
procedure). The remaining 1152 patients were treated
endoscopically.
Analysis of the two RCTs strongly supports the superi-
ority of surgical treatment when complete pain relief is the
outcome under consideration. Figure 2 depicts the forest-he best option for the management of pain in patients with chronic
Surgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.09.005
Figure 2 Meta-analysis of two RCTs. (A) Complete pain relief. (B) Partial pain relief. (C) No pain relief. (D) Morbidity.
MeH Z ManteleHaenszel method.
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(OR, 3.53; p Z 0.0008). When partial pain relief is consid-
ered, there was no statistical significance between surgery
and endoscopy (OR, 0.95; p Z 0.88). However, when
comparing the outcome of no pain relief, there is again a
significant difference in favor of surgery (OR, 3.97;
p Z 0.0003). Similarly, there were no major differences in
morbidity (p Z 0.48) or mortality (p Z 0.47) between the
two groups. One death was observed in Cahen’s original
study14 in the endoscopic group, attributed to a perforated
duodenal ulcer 4 days post extracorporeal shockwave lith-
otripsy (ESWL). During their 5-year follow-up period a
further six patients died of unrelated causes, two in the
endoscopy group and four in the surgical group. These were
excluded from the meta-analysis for pain outcomes due to
lack of data for these patients. There were a further four
morbidities in the endoscopy group, two ruptured PDs and
two pancreatic stent occlusions. Table 2 summarizes the
complications in the two RCTs.Please cite this article in press as: Jawad ZAR, et al., Surgery remains t
pancreatitis: A systematic review and meta-analysis, Asian Journal ofThe remaining 19 articles reviewed were systematically
analyzed16e34 Specifically, surgical treatment was effective
in alleviating pain symptoms completely in 58.4% of pa-
tients, partially effective in 22.0%, and completely failed in
19.4% of cases. Endoscopic treatment was effective in
64.0%, partially effective in 8.5%, and failed in 27.5%. The
ability for a treatment to give any pain relief was signifi-
cantly better after surgery (80.4%) compared with endos-
copy (72.6%; p < 0.0001).
Morbidity was higher in the surgical group (12.7%)
compared with the endoscopy group (10.1%). Mortality was
also higher at 0.6% (n Z 13), with no deaths occurring
following endoscopy.4. Discussion
The progressive nature of CP leads to at least 50% of pa-
tients developing intractable symptoms (i.e., endocrinehe best option for the management of pain in patients with chronic
Surgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.09.005
Table 1 Characteristics of studies in the review.
Study Patient
age (y),
mean
Patients treated
(n Z 2754)
Surgery
(n Z 1602)
Endoscopy
(n Z 1152)
Dite 200313 41.7 76 64
Cahen 201115 41.7 20 19
Adams 199416 43.6 62 0
Strate 200517 N/A 51 0
Berney 200018 44 67 0
Dumonceau 200719 49 0 24
Farkas 200320 44 30 0
Frey 199421 47 47 0
Izbicki 199822 43.8 61 0
Mobius 200723 N/A 51 0
Nealon 200124 43 185 0
Rosch 200225 50 0 1018
Sakorafas 200126 47 31 0
Schlosser 200227 44.7 219 0
Schlosser 200528 45.8 55 0
Schnelldorfer 200729 46 368 0
Stapleton 199630 42.2 52 0
Lucas 199931 34 124 0
Byrne 199732 47 51 0
Vasile 201333 51 17 0
Hong 201134 52 35 27
N/A Z not available.
Table 2 Complication types in the two randomized con-
trol trials.
Complications Dite et al13, 2003 Cahen et al15, 2011
Surgery Endoscopy Surgery Endoscopy
Morbidity 6 5 7 (4) 18 (6)
Acute
pancreatitis
2 2 0 4
Bleeding 0 2 2 0
Cholecystitis 0 0 0 1
Pancreatic
abscess
0 1 0 0
Fistula 2 0 0 0
Anastomotic
leak
1 0 1 n/a
Ileus 1 0 0 n/a
Wound infection 0 0 3 1
Cardiopulmonary 0 0 1 0
Stent related 0 0 n/a 5 (2)
Ruptured
pancreatic duct
0 0 0 (2)
Other minor
complications
0 0 0 7
Mortality 0 0 0 (4) 1 (2)
Numbers in brackets show additional complications at 5-year
follow up.
n/a Z not available.
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course, traditional medical treatment is usually the first to
fail in controlling the symptoms leaving endoscopic and
surgical management as the only alternatives.35,36
Endoscopy for CP usually involves a combination of
pancreatic sphincterotomy, ESWL, and PD stenting. This,
however, involves multiple procedures due to stent occlu-
sion or displacement and carries a fourfold increased risk of
associated acute pancreatitis. Radiological changes in
ductal and parenchymal morphology that are indistin-
guishable from those in CP after PD stenting have been
reported in up to 50% of patients, which supports a possible
causative association between the two.37e39 A further
downside of endoscopy is the need for compliance in pa-
tients to sustain repeated procedures, which may be
another obstacle to its success.40
Surgical treatment for CP traditionally consisted of
pancreatic head resection (e.g., Whipple’s resection) or
drainage procedures (e.g., PartingtoneRochelle).41,42 A
shift towards more conservative, less aggressive treatment
however has led to the development of pylorus preserving
pancreaticoduodenectomy and duodenum preserving
pancreatic head resection procedures as well as combina-
tion procedures (e.g., Frey’s procedure) which have been
increasingly performed successfully with minimal morbidity
and mortality.43e46 The results of the reviewed publications
show a significantly better response to surgical treatment,
with good long-term results.
However, a major limitation in this review is the lack of
randomized studies which include a relatively small num-
ber of patients. Furthermore, in the two RCTs identified
there are some important differences to note. Firstly, in
Dite et al’s13 study only 72 of 140 patients agreed to be
randomised, with the majority of the remaining patients
opting for surgery. The data in the randomised group was
analyzed individually as well as for the entire patient
group, with no significant differences. Dite et al’s13 study
included a higher number of participants (72 vs. 39), more
surgical resections than drainage procedures (80% vs.
10%), as well as a lower number of patients with intra-
ductal stones (23% vs. 95%) when compared with Cahen
et al’s14,15 study. Moreover, lithotripsy was not available,
unlike in Cahen’s series were 88% of patients in the
endoscopic group underwent ESWL. ESWL is an important
component of endoscopic treatment, and the lack of it in
the endoscopy arm may reduce its efficacy when
comparing it to surgery.
The endoscopy protocol in the Cahen study involves
repeated endoscopy as required, whereas Dite reserves
repeat only under certain circumstances such as stent
occlusion. Despite this, 47% of patients in Cahen’s group
eventually required surgery due to recurrent PD stenosis.
In these patients, only two of nine achieved complete
pain relief which suggests that delay in surgical treatment
may reduce its efficacy. Dite et al13 demonstrated
the same initial success rate in both the endoscopic and
the surgical groups, in contrast to Cahen et al14,15 who
showed an average difference of 24 points on the Izbicki
score (0e100) between the two groups, which
was consistent during the entire follow-up period.
Therefore Dite’s study only favors surgery in the long-
term management.he best option for the management of pain in patients with chronic
Surgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.09.005
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management of pain, the benefit is usually short lived and
the need to repeat the procedure is frequent.47e49
Furthermore, an overall mortality rate of 0.6% following
1622 pancreatic operations is quite remarkable and evi-
dence that as surgical techniques evolve, risk is further
minimized.50 Again a lack of properly designed, multi-
center RCTs is a limiting factor in evaluating current
practice and assessing the different modalities for treat-
ing CP, and it is important to discuss these limitations with
the patient. It may be useful to design studies that classify
different anomalies seen at endoscopic retrograde chol-
angiopancreatography (ERCP) or endoscopic ultrasound
and study the effect of treatment accordingly with the
aim of tailoring treatment to individuals. Another avenue
to evaluate is whether early surgery is more effective
rather than leaving this as a last resort. This is being
evaluated in the ESCAPE trial by the Dutch Pancreatitis
Study Group.51 It may also be useful to define suitable
treatments for low and high risk groups. However, at
present, analysis of the existing studies can provide evi-
dence that continues to support the superiority of surgical
treatment in CP.References
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